Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-25

Clinical Trial Update: A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection

View source ↗

Summary

A clinical trial update states that a study evaluating the safety and risk of hypersensitivity reactions to sulbactam-durlobactam in adults with Acinetobacter b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulbactam-durlobactam (sulbactam-durlobactam)

Snippet

Sponsor: Innoviva Specialty Therapeutics | Conditions: Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC) | Status: RECRUITING